Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 ( ) Genotype and Clopidogrel Therapy von Scott, SA, Sangkuhl, K, Gardner, EE, Stein, CM, Hulot, J‐S, Johnson, JA, Roden, DM, Klein, TE, Shuldiner, AR

Volltext

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update von Scott, S A, Sangkuhl, K, Stein, C M, Hulot, J-S, Mega, J L, Roden, D M, Klein, T E, Sabatine, M S, Johnson, J A, Shuldiner, A R

Volltext

Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes von Lin, P.I, Shuldiner, A.R

Volltext

Clopidogrel pharmacogenetics: Beyond candidate genes and genome‐wide association studies von Lewis, JP, Shuldiner, AR

Volltext

Clopidogrel: A Case for Indication-Specific Pharmacogenetics von Johnson, J A, Roden, D M, Lesko, L J, Ashley, E, Klein, T E, Shuldiner, A R

Volltext

The CYP2C1917 variant is not independently associated with clopidogrel response von Lewis, J. P., Stephens, S. H., Horenstein, R. B., O'Connell, J. R., Ryan, K., Peer, C. J., Figg, W. D., Spencer, S. D., Pacanowski, M. A., Mitchell, B. D., Shuldiner, A. R.

Volltext

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions von Beitelshees, AL, Horenstein, RB, Vesely, MR, Mehra, MR, Shuldiner, AR

Volltext

Paraoxonase 1 ( ) Gene Variants Are Not Associated With Clopidogrel Response von Lewis, J P, Fisch, A S, Ryan, K, O'Connell, J R, Gibson, Q, Mitchell, B D, Shen, H, Tanner, K, Horenstein, R B, Pakzy, R, Tantry, U S, Bliden, K P, Gurbel, P A, Shuldiner, A R

Volltext

Educational innovations in clinical pharmacogenomics von Perry, CG, Maloney, KA, Beitelshees, AL, Jeng, LJB, Ambulos Jr, NP, Shuldiner, AR, Blitzer, MG

Volltext

Identifying clinically relevant sources of variability: The clopidogrel challenge von Samant, S, Jiang, XL, Peletier, LA, Shuldiner, AR, Horenstein, RB, Lewis, JP, Lesko, LJ, Schmidt, S

Volltext

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response von Giacomini, K M, Brett, C M, Altman, R B, Benowitz, N L, Dolan, M E, Flockhart, D A, Johnson, J A, Hayes, D F, Klein, T, Krauss, R M, Kroetz, D L, McLeod, H L, Nguyen, A T, Ratain, M J, Relling, M V, Reus, V, Roden, D M, Schaefer, C A, Shuldiner, A R, Skaar, T, Tantisira, K, Tyndale, R F, Wang, L, Weinshilboum, R M, Weiss, S T, Zineh, I

Volltext

CPT1A methylation is associated with plasma adiponectin von Aslibekyan, S, Do, A.N, Xu, H, Li, S, Irvin, M.R, Zhi, D, Tiwari, H.K, Absher, D.M, Shuldiner, A.R, Zhang, T, Chen, W, Tanner, K, Hong, C, Mitchell, B.D, Berenson, G, Arnett, D.K

Volltext

Pharmacogenomics: Application to the Management of Cardiovascular Disease von Johnson, J A, Cavallari, L H, Beitelshees, A L, Lewis, J P, Shuldiner, A R, Roden, D M

Volltext

Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes von Clement, K, Hercberg, S, Passinge, B, Galan, P, Varroud-Vial, M, Shuldiner, A.R, Beamer, B.A, Charpentier, G, Guy-Grand, B, Froguel, P

Volltext

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation von Shuldiner, A R, Relling, M V, Peterson, J F, Hicks, K, Freimuth, R R, Sadee, W, Pereira, N L, Roden, D M, Johnson, J A, Klein, T E

Volltext

Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability von Ellero‐Simatos, S, Lewis, JP, Georgiades, A, Yerges‐Armstrong, LM, Beitelshees, AL, Horenstein, RB, Dane, A, Harms, AC, Ramaker, R, Vreeken, RJ, Perry, CG, Zhu, H, Sànchez, CL, Kuhn, C, Ortel, TL, Shuldiner, AR, Hankemeier, T, Kaddurah‐Daouk, R

Volltext

Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study von HSUEH, W.-C, MITCHELL, B. D, BURNS, D. K, BELL, C. J, SHULDINER, A. R, ABUROMIA, R, POLLIN, T, SAKUL, H, EHM, M. G, MICHELSEN, B. K, WAGNER, M. J, JEAN, P. L. S, KNOWLER, W. C

Volltext

Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics von Yerges-Armstrong, L M, Ellero-Simatos, S, Georgiades, A, Zhu, H, Lewis, J p, Horenstein, R B, Beitelshees, A L, Dane, A, Reijmers, T, Hankemeier, T, Fiehn, O, Shuldiner, A R, Kaddurah-Daouk, R

Volltext

Association Between Uncoupling Protein Polymorphisms (UCP2–UCP3) and Energy Metabolism/Obesity in Pima Indians von Walder, Ken, Norman, Rod A., Hanson, Robert L., Schrauwen, Patrick, Neverova, Maria, Jenkinson, Chris P., Easlick, Juliet, Warden, Craig H., Pecqueur, Claire, Raimbault, Serge, Ricquier, Daniel, Harper, Michael, Silver, Kristi, Shuldiner, Alan R., Solanes, Gemma, Lowell, Bradford B., Chung, Wendy K., Leibel, Rudolph L., Pratley, Richard, Ravussin, Eric

Volltext

CYP2C19 and Clopidogrel Response: More Than Validation in the Real World von Shuldiner, A R

Volltext